However, for the Company, 2024 was both a “year of restructuring” amidst challenges and a “year of breakthroughs” with emerging potentials. Although the overall performance is experiencing short-term ...
In our 'Shop My Routine' column, we explore the beauty routines of CEOs, tastemakers and influencers. This week we spoke with ...
Amid a measles outbreak across three states with 279 reported cases, two deaths and seemingly no end in sight, the parents of ...
Weaning patients with less-potent topical corticosteroids (10/0 hydrocortisone or desonide cream) or topical calcineurin inhibitors (1% pimecrolimus) may minimize flares (Oppel, Pavicic ...